Companies Dominating the Thoracic Vascular Stent Grafts Landscape
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- JOTEC GmbH
- Cook Group Incorporated
- Terumo Corporation
- Cardinal Health, Inc.
- LeMaitre Vascular, Inc.
- Merit Medical Systems, Inc.
- Lombard Medical Ltd
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Endologix LLC
Browse Key Market Insights with Data Illustration:
In the News
-
Terumo Corporation has launched the Thoraflex Hybrid Device for the treatment of complex aortic arch disease. The single-use device is comprised of a Gelweave polyester graft coupled to a Nitinol self-expanding stent.
-
Lifetech Scientific (Shenzhen) Co., Ltd. has attained a formal written notice from the National Medical Products Administration (“NMPA”) authorizing the admission of the Artery Stent Graft System (chimney technology) into the NMPA Special Examination and Approval Procedure for Innovative Medical Services. This is the world's first stent graft system engineered specifically for "chimney technology", a mainstream technology for treating aortic dissection lesions.
